OPKO Acquires OURLab for Prostate Cancer Platform

首页> 外文期刊>Laboratory industry report >OPKO Acquires OURLab for Prostate Cancer Platform

【24h】

OPKO Acquires OURLab for Prostate Cancer Platform

机译：OPKO为前列腺癌平台收购OURLab

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Miami-based pharmaceutical and diagnostics firm OPKO Health has acquired the controlling company for Oppenheimer Urologic Reference Laboratory, a Nashville-based laboratory owned by ProstData Inc. Terms of the transaction were not disclosed.

机译：总部位于迈阿密的制药和诊断公司OPKO Health已收购了ProstData Inc.旗下位于纳什维尔的Oppenheimer泌尿科参考实验室的控股公司。交易的具体条款尚未披露。

著录项

来源
《Laboratory industry report》 |2013年第1期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类经济;
关键词

相似文献

外文文献
中文文献
专利

1. OPKO Acquires OURLab for Prostate Cancer Platform [J] . Laboratory industry report . 2013,第1期

机译：OPKO为前列腺癌平台收购OURLab
2. Opko Introduces Prostate Cancer Test [J] . null Laboratory industry report . 2014,第8期

机译：Opko推出前列腺癌测试
3. Biosensing of prostate specific antigen (PSA) in human plasma samples using biomacromolecule encapsulation into KCC-1-npr-NH2: A new platform for prostate cancer detection [J] . International Journal of Biological Macromolecules: Structure, Function and Interactions . 2020,第期

机译：使用BioMacromolecolecule封装在KCC-1-NPR-NH2中的人血浆样品中的前列腺特异性抗原（PSA）的生物溶解：前列腺癌检测的新平台
4. Ultra-sensitive profiling of androgenic steroids in single laser capture microdissection preparations acquired from prostate cancer patients, using selective tagging, micro-scale enrichment and isotope-dilution nanoLC-MS/MS [C] . Xiaotao Duan, Mark A Titus, Oka Daizo, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：单次激光捕获微量碎石制剂的超敏感剖析从前列腺癌患者获得的，使用选择性标记，微观富集和同位素稀释Nanolc-MS / MS
5. Compartmentalized microchamber platform for the study of tumor-stroma interactions: A model of paracrine hedgehog signaling in prostate cancer. [D] . Domenech, Maribella. 2010

机译：隔室微腔平台，用于研究肿瘤-基质相互作用：前列腺癌旁分泌刺猬信号的模型。
6. A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone [O] . Ho Won Kang, Hee Youn Lee, Young Joon Byun, 2020

机译：使用液滴数字聚合酶链反应平台的新型尿mRNA签名改善了前列腺癌和前列腺特异性抗原灰色区内的良性前列腺增生之间的区别
7. Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells [O] . Aisha Naeem, Sivanesan Dakshanamurthy, Henry Walthieu, 2020

机译：预测前列腺癌的新药物适应症：用患者衍生的原发性前列腺细胞整合硅蛋白化测量网络药理学平台

OPKO Acquires OURLab for Prostate Cancer Platform

摘要

著录项

相似文献

相关主题

期刊订阅